Related Experiment Video
Updated: Jun 8, 2026
06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Oxaliplatin-induced lung fibrosis
Arpan Shah1, Zarir F Udwadia, Sachin Almel
1Departments of Chest Medicine, P.D. Hinduja Hospital, Veer Savarkar Marg, Mahim (W), Mumbai, India.
Abstract:
Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such case of rapidly evolving pulmonary fibrosis following treatment with oxaliplatin.
